Windlas Biotech informs about outcome of board meeting

08 Sep 2021 Evaluate

Windlas Biotech that Board of Directors at its Meeting held on Wednesday, September 8, 2021, has approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021. Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, the company has enclosed: Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021 and Limited Review Report on Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021. Further, the Company has already made necessary arrangement to publish the same in the Newspapers as required under the SEBI (LODR) Regulations, 2015. The meeting of the Board of Directors commenced at 1:00 pm and concluded at 2.25 pm.

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

721.85 57.80 (8.70%)
12-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.75
Dr. Reddys Lab 6045.00
Cipla 1540.70
Zydus Lifesciences 1096.45
Lupin 1607.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.